Zur Frage der Indikation einer immunsuppressiven Dauertherapie bei der Myasthenia gravis

Fasshauer, K; Rath, I

doi:10.1055/s-2007-1002313

Fortschr Neurol Psychiatr

1981

DOI: 10.1055/s-2007-1002313

|View full text |Cite

Zur Frage der Indikation einer immunsuppressiven Dauertherapie bei der Myasthenia gravis

K Fasshauer¹,

I Rath²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1987

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis

Matell

1987

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

Azathioprine may be tried for treatment of severe myasthenia gravis, in a dose of 2 mg/kg BW. With careful monitoring the side reactions may be controlled. The therapeutic response will occur after a time delay of 4-8 months. About one-third of patients with type II MG (severe, late onset, HLA B8-) will proceed to a complete but azathioprine-dependent remission, and the remaining two-thirds to a marked improvement. In type I MG (early onset, HLA B8+) azathioprine is less effective but will help keep down the need for corticosteroids or plasmapheresis.

show abstract

Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis

Matell

1987

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Zur Frage der Indikation einer immunsuppressiven Dauertherapie bei der Myasthenia gravis

Cited by 1 publication

References 15 publications

Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis

Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis

Contact Info

Product

Resources

About